Price T Rowe Associates Inc Legend Biotech Corp Call Options Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$259 Million3.96% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$206 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$197 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$197 Million0.86% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.5MShares$121 Million4.74% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.77B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...